Literature DB >> 11197356

Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction.

E Wu1, R M Judd, J D Vargas, F J Klocke, R O Bonow, R J Kim.   

Abstract

BACKGROUND: A technical advance in contrast-enhanced magnetic resonance imaging (MRI) has significantly improved image quality. We investigated whether healed myocardial infarction can be visualised as hyperenhanced regions with this new technique, and whether assessment of the transmural extent of infarction yields new physiological data.
METHODS: 82 MRI examinations were carried out in three groups: patients with healed myocardial infarction; patients with non-ischaemic cardiomyopathy; and healthy volunteers. Patients with healed myocardial infarction were prospectively enrolled after enyzmatically proven necrosis and imaged 3 months (SD 1) or 14 months (7) later. The MRI procedure used a segmented inversion-recovery gradient-echo sequence after gadolinium administration. Findings were compared with those of coronary angiography, electrocardiography, cine MRI, and creatine kinase measurements.
FINDINGS: 29 (91%) of 32 patients with infarcts imaged at 3 months (13 non-Q-wave) and all of 19 imaged at 14 months (eight non-Q-wave) showed hyperenhancement. In patients in whom the infarct-related-artery was identified by angiography, 24 of 25 imaged at 3 months and all of 14 imaged at 14 months had hyperenhancement in the appropriate territory. None of the 20 patients with non-ischaemic cardiomyopathy or the 11 healthy volunteers showed hyperenhancement. Irrespective of the presence or absence of Q waves, the majority of patients with hyperenhancement had only non-transmural involvement. Normal left-ventricular contraction was shown in seven patients examined at 3 months and three examined at 14 months, but in these cases hyperenhancement was limited to the subendocardium.
INTERPRETATION: The presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction can be accurately determined by contrast-enhanced MRI.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11197356     DOI: 10.1016/S0140-6736(00)03567-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  154 in total

1.  Diagnostic value of routine clinical parameters in acute myocardial infarction: a comparison to delayed contrast enhanced magnetic resonance imaging.

Authors:  C Klein; E Nagel
Journal:  Int J Cardiovasc Imaging       Date:  2003-10       Impact factor: 2.357

Review 2.  Fundamental concepts in myocardial viability assessment revisited: when knowing how much is "alive" is not enough.

Authors:  R J Kim; D J Shah
Journal:  Heart       Date:  2004-02       Impact factor: 5.994

3.  Detection of scarred and viable myocardium using a new magnetic resonance imaging technique: blood oxygen level dependent (BOLD) MRI.

Authors:  M Egred; A Al-Mohammad; G D Waiter; T W Redpath; S K Semple; M Norton; A Welch; S Walton
Journal:  Heart       Date:  2003-07       Impact factor: 5.994

Review 4.  Multimodality imaging for assessment of myocardial viability: nuclear, echocardiography, MR, and CT.

Authors:  James A Arrighi; Vasken Dilsizian
Journal:  Curr Cardiol Rep       Date:  2012-04       Impact factor: 2.931

5.  Myocardial area at risk after ST-elevation myocardial infarction measured with the late gadolinium enhancement after scar remodeling and T2-weighted cardiac magnetic resonance imaging.

Authors:  Jacob Lønborg; Thomas Engstrøm; Anders B Mathiasen; Niels Vejlstrup
Journal:  Int J Cardiovasc Imaging       Date:  2011-10-05       Impact factor: 2.357

6.  Integration of MR images with electroanatomical maps: feasibility and utility in guiding left ventricular substrate mapping.

Authors:  Claudio Pandozi; Serena Dottori; Carlo Lavalle; Sabina Ficili; Marco Galeazzi; Maurizio Russo; Angela Pandozi; Giovanni Camastra; Gerardo Ansalone; Massimo Santini
Journal:  J Interv Card Electrophysiol       Date:  2010-10-20       Impact factor: 1.900

Review 7.  Current and future role of cardiovascular magnetic resonance in cardiac resynchronization therapy.

Authors:  Francisco Leyva; Paul W X Foley
Journal:  Heart Fail Rev       Date:  2011-05       Impact factor: 4.214

8.  Impact of alcohol septal ablation on left anterior descending coronary artery blood flow in hypertrophic obstructive cardiomyopathy.

Authors:  Willem G van Dockum; Paul Knaapen; Mark B M Hofman; Joost P A Kuijer; Folkert J ten Cate; Jurrien M ten Berg; Aernout M Beek; Jos W R Twisk; Albert C van Rossum
Journal:  Int J Cardiovasc Imaging       Date:  2009-02-22       Impact factor: 2.357

9.  T1 Mapping in cardiomyopathy at cardiac MR: comparison with endomyocardial biopsy.

Authors:  Christopher T Sibley; Radwa A Noureldin; Neville Gai; Marcelo Souto Nacif; Songtao Liu; Evrim B Turkbey; James O Mudd; Rob J van der Geest; João A C Lima; Marc K Halushka; David A Bluemke
Journal:  Radiology       Date:  2012-10-22       Impact factor: 11.105

10.  Cardiac magnetic resonance imaging: long term reproducibility of the late enhancement signal in patients with chronic coronary artery disease.

Authors:  H Bülow; C Klein; I Kuehn; R Hollweck; S G Nekolla; K Schreiber; F Haas; J Böhm; B Schnackenburg; R Lange; M Schwaiger
Journal:  Heart       Date:  2005-09       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.